259 related articles for article (PubMed ID: 37627142)
1. The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer.
Koerner AS; Moy RH; Ryeom SW; Yoon SS
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627142
[TBL] [Abstract][Full Text] [Related]
2. Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial.
Pan L; Tian Y; Wang K; Tang J; Liu J; Zhang J; Wang M; Liu J; Xu H; Chen X
J Gastrointest Oncol; 2022 Dec; 13(6):3300-3313. PubMed ID: 36636043
[TBL] [Abstract][Full Text] [Related]
3. [Current status and prospect of perioperative therapy for locally advanced gastric cancer].
Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):101-106. PubMed ID: 33508913
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trial.
Guo H; Ding P; Sun C; Yang P; Tian Y; Liu Y; Lowe S; Bentley R; Li Y; Zhang Z; Wang D; Li Y; Zhao Q
Front Oncol; 2022; 12():927781. PubMed ID: 36091139
[TBL] [Abstract][Full Text] [Related]
5. A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRacing study.
Zhou M; Yang W; Xuan Y; Zou W; Wang Y; Zhang Z; Zhang J; Mo M; Zhou C; Liu Y; Zhang W; Zhang Z; He Y; Weng W; Tan C; Wang L; Huang D; Sheng W; Li H; Zhu H; Wang Y; Shen L; Zhang H; Wan J; Li G; Huang H; Wang Y; Zhang Z; Liu X; Xia F
BMC Cancer; 2022 Jun; 22(1):710. PubMed ID: 35764956
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant treatment for locally advanced gastric cancer].
Zhao LL; Zhao DB; Chen YT
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):907-911. PubMed ID: 33256300
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary treatment strategy for locally advanced gastric cancer: A systematic review.
Sugawara K; Kawaguchi Y; Seto Y; Vauthey JN
Surg Oncol; 2021 Sep; 38():101599. PubMed ID: 33991939
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?
Yeh JH; Yeh YS; Tsai HL; Huang CW; Chang TK; Su WC; Wang JY
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740693
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant treatment for locally advanced gastric cancer: an Asian perspective.
Kim HD; Ryu MH; Kang YK
Gastric Cancer; 2024 May; 27(3):439-450. PubMed ID: 38489111
[TBL] [Abstract][Full Text] [Related]
10. [Historical evolution and research progress of perioperative therapy of locally advanced gastric cancer].
Chen J; Ye Q; Huang F
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):196-200. PubMed ID: 30799543
[TBL] [Abstract][Full Text] [Related]
11. Comparison between upfront surgery and neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A systematic review.
Fiflis S; Papakonstantinou M; Giakoustidis A; Christodoulidis G; Louri E; Papadopoulos VN; Giakoustidis D
World J Gastrointest Surg; 2023 Aug; 15(8):1808-1818. PubMed ID: 37701690
[TBL] [Abstract][Full Text] [Related]
12. Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial.
Shi J; Li N; Tang Y; Jiang L; Yang L; Wang S; Song Y; Liu Y; Fang H; Lu N; Qi S; Chen B; Li Z; Liu S; Wang J; Wang W; Zhu S; Yang J; Li Y; Zhao D; Jin J
BMC Gastroenterol; 2022 Jul; 22(1):359. PubMed ID: 35902798
[TBL] [Abstract][Full Text] [Related]
13. The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study.
Zhang C; Wu B; Yang H; Yao Z; Zhang N; Tan F; Liu M; Xu K; Chen L; Xing J; Cui M; Su X
BMC Cancer; 2022 Nov; 22(1):1223. PubMed ID: 36443694
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant PD-1 blockade plus chemotherapy versus chemotherapy alone in locally advanced stage II-III gastric cancer: A single-centre retrospective study.
Zhang X; Zhang C; Hou H; Zhang Y; Jiang P; Zhou H; Wang L; Zhou N; Zhang X
Transl Oncol; 2023 May; 31():101657. PubMed ID: 36934638
[TBL] [Abstract][Full Text] [Related]
15. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract][Full Text] [Related]
16. [Chinese expert consensus on perioperative treatment of locally advanced gastric cancer (2021 version)].
Gastric Cancer Association, China Anti-Cancer Association
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):741-748. PubMed ID: 34530553
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial.
Hu H; Kang L; Zhang J; Wu Z; Wang H; Huang M; Lan P; Wu X; Wang C; Cao W; Hu J; Huang Y; Huang L; Wang H; Shi L; Cai Y; Shen C; Ling J; Xie X; Cai Y; He X; Dou R; Zhou J; Ma T; Zhang X; Luo S; Deng W; Ling L; Liu H; Deng Y
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):38-48. PubMed ID: 34688374
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival results of patients with locally advanced gastric cancer and pathological complete response after neoadjuvant chemotherapy and resection.
Wang T; Wang N; Zhou H; Zhou A; Jin J; Chen Y; Zhao D
Transl Cancer Res; 2020 Feb; 9(2):529-535. PubMed ID: 35117397
[TBL] [Abstract][Full Text] [Related]
19. Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer.
Zhang Y; Zhang B; Yang J; Zhang J; Zhang W
Cancer Manag Res; 2021; 13():2279-2286. PubMed ID: 33732020
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
